These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 169045)

  • 21. MaTu--a contaminant or an anti-cancer vaccine?
    Závada J
    Folia Biol (Praha); 1993; 39(4):167-77. PubMed ID: 8187895
    [No Abstract]   [Full Text] [Related]  

  • 22. Parental G protein reincorporation by a vesicular stomatitis virus temperature-sensitive mutant of complementation group V at nonpermissive temperature.
    Deutsch V
    Virology; 1976 Feb; 69(2):607-16. PubMed ID: 176787
    [No Abstract]   [Full Text] [Related]  

  • 23. Breast cancer skin test antigens of increased sensitivity prepared from vesicular stomatitis virus-infected tumor cells.
    Austin FC; Boone CW; Levin DL; Cavins JA; Djerassi I; Rosner D; Case R; Klein E
    Cancer; 1982 May; 49(10):2034-42. PubMed ID: 6280832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of temperature-sensitive mutants of vesicular stomatitis virus.
    Holloway AF; Wong PK; Cormack DV
    Virology; 1970 Dec; 42(4):917-26. PubMed ID: 4321310
    [No Abstract]   [Full Text] [Related]  

  • 25. Natural infection of humans, animals, and phlebotomine sand flies with the Alagoas serotype of vesicular stomatitis virus in Colombia.
    Tesh RB; Boshell J; Modi GB; Morales A; Young DG; Corredor A; Ferro de Carrasquilla C; de Rodriguez C; Walters LL; Gaitan MO
    Am J Trop Med Hyg; 1987 May; 36(3):653-61. PubMed ID: 3034087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody against an antigen selectively assembled into vesicular stomatitis virus virions from HeLa cells.
    Poláková K; Závadová Z; Závada J; Russ G
    Int J Cancer; 1984 Jul; 34(1):91-4. PubMed ID: 6086535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identity of HeLa cell determinants acquired by vesicular stomatitis virus with a tumor antigen.
    Little LM; Zavada J; Der CJ; Huang AS
    Science; 1983 Jun; 220(4601):1069-71. PubMed ID: 6302845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective interfering particles with covalently linked [+/-]RNA induce interferon.
    Marcus PI; Sekellick MJ
    Nature; 1977 Apr; 266(5605):815-9. PubMed ID: 194158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vesicular stomatitis virus maturation sites in six different host cells.
    Zee YC; Hackett AJ; Talens L
    J Gen Virol; 1970; 7(2):95-102. PubMed ID: 4316780
    [No Abstract]   [Full Text] [Related]  

  • 30. Serological monitoring of vesicular stomatitis New Jersey virus in enzootic regions of Costa Rica.
    Rodriguez LL; Vernon S; Morales AI; Letchworth GJ
    Am J Trop Med Hyg; 1990 Mar; 42(3):272-81. PubMed ID: 2156464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic mixing of vesicular stomatitis virus with fowl plague virus.
    Závada J; Rosenbergová M
    Acta Virol; 1972 Mar; 16(2):103-14. PubMed ID: 4401067
    [No Abstract]   [Full Text] [Related]  

  • 32. Full-length viral RNA synthesized in vitro by vesicular stomatitis virus-infected HeLa cell extracts.
    Batt-Humphries S; Simonsen C; Ehrenfeld E
    Virology; 1979 Jul; 96(1):88-99. PubMed ID: 223312
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the serum neutralization test and a competitive enzyme-linked immunosorbent assay for the detection of antibodies to vesicular stomatitis virus New Jersey and vesicular stomatitis virus Indiana.
    Alvarado JF; Dolz G; Herrero MV; McCluskey B; Salman M
    J Vet Diagn Invest; 2002 May; 14(3):240-2. PubMed ID: 12033681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral messenger RNA unmethylated in the 5'-terminal guanosine in interferon-treated HeLa cells infected with vesicular stomatitis virus.
    de Ferra F; Baglioni C
    Virology; 1981 Jul; 112(2):426-35. PubMed ID: 6167059
    [No Abstract]   [Full Text] [Related]  

  • 35. A vesicular stomatitis virus (cytomegalovirus) pseudotype and its use in neutralization tests.
    Vonka V; Závadová H; Poláková D
    Intervirology; 1979; 12(1):32-8. PubMed ID: 227814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vesicular stomatitis virus can establish persistent infections in Syrian hamsters.
    Fultz PN; Shadduck JA; Kang CY; Streilein JW
    J Gen Virol; 1982 Dec; 63(2):493-7. PubMed ID: 6296291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo methylation of vesicular stomatitis virus and its host-cell messenger RNA species.
    Moyer SA; Banerjee AK
    Virology; 1976 Apr; 70(2):339-51. PubMed ID: 178093
    [No Abstract]   [Full Text] [Related]  

  • 39. Absence of transcriptase activity or transcription-inhibiting ability in defective interfering particles of vesicular stomatitis virus.
    Perrault J; Holland JJ
    Virology; 1972 Oct; 50(1):150-70. PubMed ID: 4343109
    [No Abstract]   [Full Text] [Related]  

  • 40. Neutralized vesicular stomatitis virus binds to host cells by a different "receptor".
    Schlegel R; Wade M
    Biochem Biophys Res Commun; 1983 Jul; 114(2):774-8. PubMed ID: 6309179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.